Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
1 clinical trials · Condition
◉ Watch Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
| Record | Firm | Date |
|---|---|---|
| Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma (NCT00596804) | Gilead Sciences | 2004-03-01 |
Track Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic automatically
Every clearance here is in the API, with alerts when new ones post.